BCL11A and sickle cell disease: Genome-wide association studies (GWAS) have found that genetic variants at the BCL11A locus are associated with fetal hemoglobin expression levels, and targeting BCL11A could prevent or ameliorate complications of sickle cell disease by regulating γ-globin expression levels11,12.